CERVOMED INC (CRVO) Forecast, Price Target & Analyst Ratings

NASDAQ:CRVO • US15713L1098

Current stock price

3.95 USD
+0.03 (+0.77%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CERVOMED INC (CRVO).

Forecast Snapshot

Consensus Price Target

Price Target
$22.88
+ 479.17% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.66
Revenue Estimate
76.5K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$22.88
Upside
+ 479.17%
From current price of $3.95 to mean target of $22.88, Based on 14 analyst forecasts
Low
$15.15
Median
$20.40
High
$32.55

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for CRVO. The average price target is 22.88 USD. This implies a price increase of 479.17% is expected in the next year compared to the current price of 3.95.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CRVO Current Analyst RatingCRVO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

CRVO Historical Analyst RatingsCRVO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
81.43%
CRVO was analyzed by 14 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CRVO.
In the previous month the buy percentage consensus was at a similar level.
CRVO was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-19D. Boral CapitalMaintains Buy -> Buy
2026-03-18Chardan CapitalMaintains Buy -> Buy
2026-03-18Roth CapitalMaintains Buy -> Buy
2026-03-16D. Boral CapitalMaintains Buy -> Buy
2026-03-05Chardan CapitalMaintains Buy -> Buy
2026-03-04D. Boral CapitalMaintains Buy -> Buy
2026-02-18D. Boral CapitalMaintains Buy -> Buy
2025-12-18Cantor FitzgeraldInitiate Overweight
2025-12-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-12-05D. Boral CapitalMaintains Buy -> Buy
2025-12-02D. Boral CapitalMaintains Buy -> Buy
2025-11-11D. Boral CapitalMaintains Buy -> Buy
2025-11-05HC Wainwright & Co.Upgrade Neutral -> Buy
2025-11-04D. Boral CapitalMaintains Buy -> Buy
2025-09-08HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-08-18D. Boral CapitalMaintains Buy -> Buy
2025-08-12Roth CapitalReiterate Buy -> Buy
2025-08-11D. Boral CapitalMaintains Buy -> Buy
2025-08-11Chardan CapitalMaintains Buy -> Buy
2025-07-29Canaccord GenuityMaintains Buy -> Buy
2025-07-28D. Boral CapitalMaintains Buy -> Buy
2025-07-25D. Boral CapitalMaintains Buy -> Buy
2025-06-11D. Boral CapitalMaintains Buy -> Buy
2025-05-13D. Boral CapitalMaintains Buy -> Buy
2025-05-12Chardan CapitalMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.66
Revenue Estimate
76.5K
Revenue Q2Q
-96.01%
EPS Q2Q
-17.30%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
-65.91%
Revenue (3 Months)
-72.73%
EPS (1 Month)
-14.59%
EPS (3 Months)
-6.01%

Next Earnings Summary

CRVO is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.66 USD and the consensus revenue estimate is 76.50K USD.
The next earnings revenue estimate has been revised downward by 72.73% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CRVO revenue by date.CRVO revenue by date.
7.145M9.738M
36.29%		4.007M
-58.86%
-100.00%		59.527M134.69M
126.27%		1.032B
666.20%		1.988B
92.64%		2.614B
31.49%
EBITDA
YoY % growth
CRVO ebitda by date.CRVO ebitda by date.
N/A
8.03%		N/A
-18.75%		N/A
-61.40%		-64.26M
-128.26%		-74.256M
-15.56%		-75.48M
-1.65%		-49.98M
33.78%		-220.32M
-340.82%		130.05M
159.03%		414.63M
218.82%		679.01M
63.76%
EBIT
YoY % growth
CRVO ebit by date.CRVO ebit by date.
-7.013M
56.09%		-18.227M
-159.91%		-28.295M
-55.24%		-46.51M
-64.37%		-56.38M
-21.22%		-63.481M
-12.60%		-2.558M
95.97%		-15.584M
-509.26%		776.62M
5,083.48%		1.613B
107.69%		2.16B
33.91%
Operating Margin
CRVO operating margin by date.CRVO operating margin by date.
-98.15%-187.17%-706.22%N/AN/AN/A-4.30%-11.57%75.25%81.14%82.63%
EPS
YoY % growth
CRVO eps by date.CRVO eps by date.
N/A
82.98%		-2.03
-47.42%		-2.98
-46.80%		-1.93
35.19%		-1.47
23.94%		-1.26
13.89%		-0.72
43.01%		-1.23
-70.27%		5.51
549.32%		11.03
100.06%		14.62
32.51%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.66
-17.30%		-0.48
31.22%		-0.55
34.43%		-0.61
31.15%
Revenue
Q2Q % growth		76.5K
-96.01%		285.6K
-83.75%		285.6K
-11.46%		306K
3,300.00%
EBITDA
Q2Q % growth		-9.996M
-58.06%		-10.71M
-69.35%		-19.176M
-141.03%		-24.48M
-211.69%
EBIT
Q2Q % growth		-8.875M
-67.37%		-9.319M
-40.86%		-12.096M
-50.37%		-13.849M
-66.22%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CRVO Yearly Revenue VS EstimatesCRVO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
CRVO Yearly EPS VS EstimatesCRVO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.36%
EPS Next 5 Year
9.69%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
93.70%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-39.40%
EBIT Next 5 Year
-51.22%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CERVOMED INC / CRVO Forecast FAQ

What is the price target for CRVO stock?

14 analysts have analysed CRVO and the average price target is 22.88 USD. This implies a price increase of 479.17% is expected in the next year compared to the current price of 3.95.

Can you provide the upcoming earnings date for CERVOMED INC?

CERVOMED INC (CRVO) will report earnings on 2026-05-11.

What are the consensus estimates for CRVO stock next earnings?

The consensus EPS estimate for the next earnings of CERVOMED INC (CRVO) is -0.66 USD and the consensus revenue estimate is 76.50K USD.

What is the expected long term growth rate for CERVOMED INC (CRVO)?

The expected long term growth rate for CERVOMED INC (CRVO) is -25.99%.